These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34746691)

  • 81. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.
    Mahdessian H; Taxiarchis A; Popov S; Silveira A; Franco-Cereceda A; Hamsten A; Eriksson P; van't Hooft F
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8913-8. PubMed ID: 24927523
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study.
    Kalafati IP; Dimitriou M; Borsa D; Vlachogiannakos J; Revenas K; Kokkinos A; Ladas SD; Dedoussis GV
    Eur J Nutr; 2019 Jun; 58(4):1463-1473. PubMed ID: 29574608
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients.
    Raia GYS; Abdelsameea E; Taie DHT; Elshaarawy O; Bayomy NR; Mostafa RG; Alsharnoby AAA; Diab KA
    Clin Exp Hepatol; 2022 Sep; 8(3):211-218. PubMed ID: 36685261
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 85. TM6SF2: A novel target for plasma lipid regulation.
    Li TT; Li TH; Peng J; He B; Liu LS; Wei DH; Jiang ZS; Zheng XL; Tang ZH
    Atherosclerosis; 2018 Jan; 268():170-176. PubMed ID: 29232562
    [TBL] [Abstract][Full Text] [Related]  

  • 86. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
    Liu YL; Reeves HL; Burt AD; Tiniakos D; McPherson S; Leathart JB; Allison ME; Alexander GJ; Piguet AC; Anty R; Donaldson P; Aithal GP; Francque S; Van Gaal L; Clement K; Ratziu V; Dufour JF; Day CP; Daly AK; Anstee QM
    Nat Commun; 2014 Jun; 5():4309. PubMed ID: 24978903
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease.
    Danford CJ; Connelly MA; Shalaurova I; Kim M; Herman MA; Nasser I; Otvos JD; Afdhal NH; Jiang ZG; Lai M
    Hepatol Commun; 2018 Dec; 2(12):1467-1478. PubMed ID: 30556036
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based Study.
    Alsaif F; Al-Hamoudi W; Alotaiby M; Alsadoon A; Almayouf M; Almadany H; Abuhaimed J; Ghufran N; Merajuddin A; Ali Khan I
    Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557278
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lipoprotein metabolism in liver diseases.
    Perez-Matos MC; Sandhu B; Bonder A; Jiang ZG
    Curr Opin Lipidol; 2019 Feb; 30(1):30-36. PubMed ID: 30550414
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis.
    Shankarappa B; Mahadevan J; Murthy P; Purushottam M; Viswanath B; Jain S; Devarbhavi H; Mysore V A
    Indian J Gastroenterol; 2023 Dec; 42(6):800-807. PubMed ID: 37589914
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
    Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
    Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus.
    Liu J; Qi W; Wang S; Zhang Y; Wang X; Sun D; Xu Y; Shi J; Duan H; Zhang Q; Wang H; Wang J
    Lipids Health Dis; 2023 Jul; 22(1):91. PubMed ID: 37400794
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
    Arslanow A; Stokes CS; Weber SN; Grünhage F; Lammert F; Krawczyk M
    Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography.
    Caussy C; Bhargava M; Villesen IF; Gudmann NS; Leeming DJ; Karsdal MA; Faulkner C; Bao D; Liu A; Lo MT; Bettencourt R; Bassirian S; Richards L; Brenner DA; Chen CH; Sirlin CB; Loomba R
    Hepatology; 2019 Jul; 70(1):127-141. PubMed ID: 30859582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.
    Wang X; Liu Z; Wang K; Wang Z; Sun X; Zhong L; Deng G; Song G; Sun B; Peng Z; Liu W
    Front Genet; 2016; 7():140. PubMed ID: 27532011
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD.
    Ezaz G; Trivedi HD; Connelly MA; Filozof C; Howard K; L Parrish M; Kim M; Herman MA; Nasser I; Afdhal NH; Jiang ZG; Lai M
    Hepatol Commun; 2020 May; 4(5):670-680. PubMed ID: 32363318
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups.
    Boonvisut S; Nakayama K; Makishima S; Watanabe K; Miyashita H; Lkhagvasuren M; Kagawa Y; Iwamoto S
    Lipids Health Dis; 2016 Jan; 15():8. PubMed ID: 26758378
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.
    Tricò D; Caprio S; Rosaria Umano G; Pierpont B; Nouws J; Galderisi A; Kim G; Mata MM; Santoro N
    Hepatology; 2018 Oct; 68(4):1376-1390. PubMed ID: 29665034
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Icariin improves testicular dysfunction via enhancing proliferation and inhibiting mitochondria-dependent apoptosis pathway in high-fat diet and streptozotocin-induced diabetic rats.
    He W; Liu H; Hu L; Wang Y; Huang L; Liang A; Wang X; Zhang Q; Chen Y; Cao Y; Li S; Wang J; Lei X
    Reprod Biol Endocrinol; 2021 Nov; 19(1):168. PubMed ID: 34753504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.